Share on Facebook
European Joint Action on Vaccination (EU‐JAV) launched in Paris
EU-JAV is coordinated by France's National Institute of Health and Medical Research with the support of the Ministry of Health and Solidarities. By sharing tools for stronger national responses to vaccination challenges, EU‐JAV aims at spurring long‐lasting European cooperation against vaccine‐preventable diseases.
Cross-border Healthcare Directive – Implementation Report published
During the last three years, the Directive on Cross-border Healthcare (2011/24/EU) has proven to clarify and guarantee patients' rights to receive healthcare in another Member State. Since the adoption of the Directive, no further European court rulings were needed to ensure these rights.
World Heart Day – Statement from Commissioner Andriukaitis
With 6 million new cases diagnosed and around 1.8 million people dying yearly of heart-related diseases in the EU, it is a day where each of us should stop for a moment and think what promises we can make and keep to decrease these staggering numbers.
Improving understanding of biosimilars in the EU – new material for healthcare professionals
The European Medicines Agency and the European Commission have published additional information material on biosimilar medicines. A biosimilar is biological medicine that is highly similar in all essential aspects to a 'reference' biological medicine already authorised.
"One Health" approach key in tackling AMR – resolution adopted by the European Parliament
In the non-binding resolution, adopted early September 2018 MEPs stress that the correct and prudent use of antimicrobials is essential to limit antimicrobial resistance (AMR) from emerging in human healthcare, animal husbandry and aquaculture.
World Heart Day
Statement ahead of World Heart Day by Commissioner for Health and Food Safety, Vytenis Andriukaitis
Non-communicable diseases
Speech by Commissioner Andriukaitis at the Plenary Session of the United Nations General Assembly High-Level Meeting on the Prevention & Control of Non-Communicable Diseases
Medicinal products
New documents on Falsified medicines - Safety features
Medicinal products
Patients' organisation representatives: Call for expressions of interest for the EMA PRAC (Deadline for submission of applications : 4 November 2018)
